You have the choice:
This innovative implant was made for you
From broken bones to plastic surgery to correcting malpositions - of the millions of implants surgically implanted in the body during orthopaedic operations, a not inconsiderable number have to be removed again because they give rise to undesirable reactions. The second operation is always associated with potential risks for the patients: the surgery can damage blood vessels or nerves, and the anaesthetic and possible infection are additional risks, not to mention the pain arising from the operation and the sick time involved (average up to 3 days away from work) and of course, the restricted mobility.
The most widespread type of implants to date are made of titanium or steel because of their stability and strength. But most of the instances in which they are used actually only need temporary stabilisation and fixation of the bone until it is healed - afterwards, the permanent implants remain "functionless" in the body, and can give rise to foreign body reactions.
If these risks are to be avoided, one can also use resorbable polymer implants instead (based on polyglycolic acid and/or polylactic acid, PGA/PLA), but their use is strongly restricted because of their low mechanical properties.
MAGNEZIX® implants offer you both, they combine the proven stability of metallic implants with the resorbability of polymers, but without the disadvantages of these systems - a sensational progress!
Everyone can profit from MAGNEZIX®
Less pain, fewer risks, less worry
Hardly any of us like the idea of metal remaining permanently behind in the body after an operation if this can be avoided. And even worse, we do not want to have to undergo another operation to remove the metal because we all know about the risks of any operation, and also want to remain as mobile as possible. These are precisely the reasons why implants made of MAGNEZIX® are the much more convincing alternative:
- MAGNEZIX® is the world's first magnesium alloy for biotransformable implants to have gained official approval.
- When magnesium degrades, it creates an antibacterial, infection-inhibiting environment. MAGNEZIX® implants promote bone growth and are transformed into normal bone tissue.
- The bone-like properties prevent bone shrinkage during the immobilisation period.
- And the controlled bioresorption of MAGNEZIX® makes a second operation to remove metal completely unnecessary, and no foreign material remains behind in the body.
- It also has very good biocompatibility and tolerance, and no allergies have ever been reported.
Stong as bone, but no strain on the body
The MAGNEZIX® implants are simply resorbed by the body. And more: they promote bone growth and are themselves gradually turned into bone. Moreover, they have an anti-infective effect. The screws contain more than 90% magnesium, which is about 150 mg with a MAGNEZIX® CS 3.2 (20 mm length). This quantity corresponds roughly to the magnesium content of three large bottles of mineral water and is negligible compared to the total body-magnesium content - in particular because the screw is transformed over a long period of time.
- Fewer risks (infection, anaesthetic)
- Less pain
- Less stress
- Less loss of time (days sick, time off work)
MAGNEZIX® - the implant of the future
First heal, then dissolve: The MAGNEZIX® principle
Metal that turns into bone - a new standard for implants. This brief introduction gives an overview of the unique advantages and benefits of MAGNEZIX®.
Costs and Reimbursement of MAGNEZIX®
The innovative MAGNEZIX® magnesium implants are somewhat more expensive than conventional titanium screws, however, the costs incurred during outpatient procedures are reimbursed directly to the doctor by the health insurance company. In stationary operations MAGNEZIX® implants are contained in the so-called DRGs which the hospital gets for treatment.
The advantages are overwhelming: Individual cost carriers even strive for direct cooperation agreements with Syntellix - no wonder because these unique implants help to avoid complications and illnesses and to reduce the costs of material removal in Germany of over one billion euros.